A business in context

HRTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-23 · 0001193125-26-407728 · Items 1.01,9.01

  2. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-352403 · Items 1.01,3.03,9.01

  3. 4 · Ownership change

    Report date 2026-08-06 · 0001193125-26-341528

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-341301

  5. 8-K · Current report

    Report date 2026-08-10 · 0001193125-26-341300 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-07-31 · 0001193125-26-329848

  7. 4 · Ownership change

    Report date 2026-07-30 · 0001193125-26-329804

  8. 4 · Ownership change

    Report date 2026-07-30 · 0001193125-26-329720

  9. 4 · Ownership change

    Report date 2026-07-30 · 0001193125-26-329694

  10. 4 · Ownership change

    Report date 2026-07-19 · 0001193125-26-308958

  11. 4 · Ownership change

    Report date 2026-07-19 · 0001193125-26-308922

  12. 4 · Ownership change

    Report date 2026-07-19 · 0001193125-26-308887

  13. 8-K · Current report

    Report date 2026-06-25 · 0001193125-26-282988 · Items 3.01,9.01

  14. 8-K · Current report

    Report date 2026-06-11 · 0001193125-26-272388 · Items 5.07

  15. 8-K · Current report

    Report date 2026-06-02 · 0001193125-26-253851 · Items 8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-215755

  17. 8-K · Current report

    Report date 2026-05-11 · 0001193125-26-215752 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-04-30 · 0001193125-26-196306

  19. 8-K · Current report

    Report date 2026-04-03 · 0001193125-26-142947 · Items 5.02,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-073515

  21. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073502 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-09 · 0001193125-26-008631 · Items 7.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-263618

  24. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-263617 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-10-27 · 0001193125-25-256300 · Items 5.02,7.01,9.01

  26. 8-K · Current report

    Report date 2025-10-15 · 0001193125-25-240253 · Items 5.07,9.01

  27. DEF 14A · Proxy statement

    Report date 2025-10-13 · 0001193125-25-209064

  28. 8-K · Current report

    Report date 2025-08-22 · 0000950170-25-112048 · Items 1.01,9.01

  29. 8-K · Current report

    Report date 2025-08-13 · 0000950170-25-109234 · Items 1.01,3.03,5.03,8.01,9.01

  30. 8-K · Current report

    Report date 2025-08-08 · 0000950170-25-107416 · Items 1.01,5.03,8.01,9.01

  31. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-107404 · Items 1.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105475

  33. 8-K · Current report

    Report date 2025-08-08 · 0000950170-25-105474 · Items 1.01,2.02,2.03,3.02,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-12 · 0000950170-25-087555 · Items 5.07

  35. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-063973 · Items 2.02,9.01

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-063971

  37. 8-K · Current report

    Report date 2025-05-06 · 0000950170-25-063967 · Items 8.01,9.01

  38. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0000950170-25-060882

  39. 8-K · Current report

    Report date 2025-04-28 · 0000950170-25-059479 · Items 5.02,9.01

  40. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-028374

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 22 transaction rows22MTax / exercise payment: 7 transaction rows7FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

29 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-06
2026-08-10
Hensley Mark EarlM · Exercise / conversion
Acquired
Common Stock31250.0n/a
2026-08-06
2026-08-10
Hensley Mark EarlF · Tax / exercise payment
Disposed
Common Stock8888.00.5
2026-08-06
2026-08-10
Hensley Mark EarlM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
31250.00.0
2026-07-31
2026-08-03
Hensley Mark EarlM · Exercise / conversion
Acquired
Common Stock11769.0n/a
2026-07-31
2026-08-03
Hensley Mark EarlM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
11769.00.0
2026-07-31
2026-08-03
Forbes William PM · Exercise / conversion
Acquired
Common Stock11694.0n/a
2026-07-31
2026-08-03
Forbes William PF · Tax / exercise payment
Disposed
Common Stock3326.00.5
2026-07-31
2026-08-03
Forbes William PM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
11694.00.0
2026-07-31
2026-08-03
Duarte IraM · Exercise / conversion
Acquired
Common Stock11694.0n/a
2026-07-31
2026-08-03
Duarte IraF · Tax / exercise payment
Disposed
Common Stock3326.00.5
2026-07-31
2026-08-03
Duarte IraM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
11694.00.0
2026-07-31
2026-08-03
Collard Craig AM · Exercise / conversion
Acquired
Common Stock34789.0n/a
2026-07-31
2026-08-03
Collard Craig AM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34789.00.0
2026-07-30
2026-08-03
Forbes William PF · Tax / exercise payment
Disposed
Common Stock3348.00.5
2026-07-30
2026-08-03
Forbes William PM · Exercise / conversion
Acquired
Common Stock11769.0n/a
2026-07-30
2026-08-03
Forbes William PM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
11769.00.0
2026-07-30
2026-08-03
Duarte IraF · Tax / exercise payment
Disposed
Common Stock3850.00.5
2026-07-30
2026-08-03
Duarte IraM · Exercise / conversion
Acquired
Common Stock13535.0n/a
2026-07-30
2026-08-03
Duarte IraM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
13535.00.0
2026-07-30
2026-08-03
Collard Craig AM · Exercise / conversion
Acquired
Common Stock50021.0n/a
2026-07-30
2026-08-03
Collard Craig AM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
50021.00.0
2026-07-19
2026-07-20
Collard Craig AM · Exercise / conversion
Acquired
Common Stock13797.0n/a
2026-07-19
2026-07-20
Collard Craig AM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
13797.00.0
2026-07-19
2026-07-20
Forbes William PF · Tax / exercise payment
Disposed
Common Stock1101.00.47
2026-07-19
2026-07-20
Forbes William PM · Exercise / conversion
Acquired
Common Stock3874.0n/a
2026-07-19
2026-07-20
Forbes William PM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
3874.00.0
2026-07-19
2026-07-20
Duarte IraM · Exercise / conversion
Acquired
Common Stock3874.0n/a
2026-07-19
2026-07-20
Duarte IraF · Tax / exercise payment
Disposed
Common Stock1101.00.47
2026-07-19
2026-07-20
Duarte IraM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
3874.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000818033HERON THERAPEUTICS, INC. /DE/

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • AP PHARMA INC /DE/ · former SEC name · 2001-11-13 to 2014-01-07
  • ADVANCED POLYMER SYSTEMS INC /DE/ · former SEC name · 1994-02-01 to 2001-04-06

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$144.28M$154.98M
2023-12-31$127.04M$140.48M
2022-12-31$107.67M$123.94M
2021-12-31$86.35M$107.35M
2020-12-31$88.64M$115.39M
2019-12-31$145.97M$192.36M
2018-12-31$77.47M$103.95M
2017-12-31$30.77M$42.29M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗